Managing Growth Deceleration Associated With Attention-Deficit/Hyperactivity Disorder and Stimulant-Induced Appetite Suppression

Attention-deficit/hyperactivity disorder (ADHD) has been diagnosed in 9.8% of children ages 3 to 17 years in the United States according to Centers for Disease Control and Prevention data from 2016 to 2019, and 62% of children with ADHD take medication as part of their treatment.¹ Due to their well-established safety profile and high efficacy, central nervous system stimulants are used as first-line treatment for symptom reduction in children with ADHD.² For each patient, benefits of stimulant…

via https://pubmed.ncbi.nlm.nih.gov/38461891/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20240326020906&v=2.18.0.post9+e462414